Cargando…
Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians
There have been no comprehensive studies of a full range of blood group polymorphisms within the Australian population. This problem is compounded by the absence of any databases carrying genomic information on chronically transfused patients and low frequency blood group antigens in Australia. Here...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636324/ https://www.ncbi.nlm.nih.gov/pubmed/35420653 http://dx.doi.org/10.1182/bloodadvances.2022007505 |
_version_ | 1784824920777162752 |
---|---|
author | Jadhao, Sudhir Davison, Candice Roulis, Eileen V. Lee, Simon Lacaze, Paul Riaz, Moeen McNeil, John J. Thomas, David M. Pecheniuk, Natalie M. Hyland, Catherine A. Flower, Robert L. Nagaraj, Shivashankar H. |
author_facet | Jadhao, Sudhir Davison, Candice Roulis, Eileen V. Lee, Simon Lacaze, Paul Riaz, Moeen McNeil, John J. Thomas, David M. Pecheniuk, Natalie M. Hyland, Catherine A. Flower, Robert L. Nagaraj, Shivashankar H. |
author_sort | Jadhao, Sudhir |
collection | PubMed |
description | There have been no comprehensive studies of a full range of blood group polymorphisms within the Australian population. This problem is compounded by the absence of any databases carrying genomic information on chronically transfused patients and low frequency blood group antigens in Australia. Here, we use RBCeq, a web server–based blood group genotyping software, to identify unique blood group variants among Australians and compare the variation detected vs global data. Whole-genome sequencing data were analyzed for 2796 healthy older Australians from the Medical Genome Reference Bank and compared with data from 1000 Genomes phase 3 (1KGP3) databases comprising 661 African, 347 American, 503 European, 504 East Asian, and 489 South Asian participants. There were 661 rare variants detected in this Australian sample population, including 9 variants that had clinical associations. Notably, we identified 80 variants that were computationally predicted to be novel and deleterious. No clinically significant rare or novel variants were found associated with the genetically complex ABO blood group system. For the Rh blood group system, 2 novel and 15 rare variants were found. Our detailed blood group profiling results provide a starting point for the creation of an Australian blood group variant database. |
format | Online Article Text |
id | pubmed-9636324 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-96363242022-11-07 Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians Jadhao, Sudhir Davison, Candice Roulis, Eileen V. Lee, Simon Lacaze, Paul Riaz, Moeen McNeil, John J. Thomas, David M. Pecheniuk, Natalie M. Hyland, Catherine A. Flower, Robert L. Nagaraj, Shivashankar H. Blood Adv Transfusion Medicine There have been no comprehensive studies of a full range of blood group polymorphisms within the Australian population. This problem is compounded by the absence of any databases carrying genomic information on chronically transfused patients and low frequency blood group antigens in Australia. Here, we use RBCeq, a web server–based blood group genotyping software, to identify unique blood group variants among Australians and compare the variation detected vs global data. Whole-genome sequencing data were analyzed for 2796 healthy older Australians from the Medical Genome Reference Bank and compared with data from 1000 Genomes phase 3 (1KGP3) databases comprising 661 African, 347 American, 503 European, 504 East Asian, and 489 South Asian participants. There were 661 rare variants detected in this Australian sample population, including 9 variants that had clinical associations. Notably, we identified 80 variants that were computationally predicted to be novel and deleterious. No clinically significant rare or novel variants were found associated with the genetically complex ABO blood group system. For the Rh blood group system, 2 novel and 15 rare variants were found. Our detailed blood group profiling results provide a starting point for the creation of an Australian blood group variant database. The American Society of Hematology 2022-04-18 /pmc/articles/PMC9636324/ /pubmed/35420653 http://dx.doi.org/10.1182/bloodadvances.2022007505 Text en Copyright © 2022 The American Society of Hematology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Transfusion Medicine Jadhao, Sudhir Davison, Candice Roulis, Eileen V. Lee, Simon Lacaze, Paul Riaz, Moeen McNeil, John J. Thomas, David M. Pecheniuk, Natalie M. Hyland, Catherine A. Flower, Robert L. Nagaraj, Shivashankar H. Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians |
title | Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians |
title_full | Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians |
title_fullStr | Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians |
title_full_unstemmed | Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians |
title_short | Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians |
title_sort | using whole-genome sequencing to characterize clinically significant blood groups among healthy older australians |
topic | Transfusion Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636324/ https://www.ncbi.nlm.nih.gov/pubmed/35420653 http://dx.doi.org/10.1182/bloodadvances.2022007505 |
work_keys_str_mv | AT jadhaosudhir usingwholegenomesequencingtocharacterizeclinicallysignificantbloodgroupsamonghealthyolderaustralians AT davisoncandice usingwholegenomesequencingtocharacterizeclinicallysignificantbloodgroupsamonghealthyolderaustralians AT rouliseileenv usingwholegenomesequencingtocharacterizeclinicallysignificantbloodgroupsamonghealthyolderaustralians AT leesimon usingwholegenomesequencingtocharacterizeclinicallysignificantbloodgroupsamonghealthyolderaustralians AT lacazepaul usingwholegenomesequencingtocharacterizeclinicallysignificantbloodgroupsamonghealthyolderaustralians AT riazmoeen usingwholegenomesequencingtocharacterizeclinicallysignificantbloodgroupsamonghealthyolderaustralians AT mcneiljohnj usingwholegenomesequencingtocharacterizeclinicallysignificantbloodgroupsamonghealthyolderaustralians AT thomasdavidm usingwholegenomesequencingtocharacterizeclinicallysignificantbloodgroupsamonghealthyolderaustralians AT pecheniuknataliem usingwholegenomesequencingtocharacterizeclinicallysignificantbloodgroupsamonghealthyolderaustralians AT hylandcatherinea usingwholegenomesequencingtocharacterizeclinicallysignificantbloodgroupsamonghealthyolderaustralians AT flowerrobertl usingwholegenomesequencingtocharacterizeclinicallysignificantbloodgroupsamonghealthyolderaustralians AT nagarajshivashankarh usingwholegenomesequencingtocharacterizeclinicallysignificantbloodgroupsamonghealthyolderaustralians |